Centrum Medische Genetica Centrum Medische Genetica

DNA methylation profiling of primary neuroblastoma tumors using methyl-CpG-binding domain sequencing.

Abstract: Comprehensive genome-wide DNA methylation studies in neuroblastoma (NB), a childhood tumor that originates from precursor cells of the sympathetic nervous system, are scarce. Recently, we profiled the DNA methylome of 102 well-annotated primary NB tumors by methyl-CpG-binding domain (MBD) sequencing, in order to identify prognostic biomarker candidates. In this data descriptor, we give details on how this data set was generated and which bioinformatics analyses were applied during data processing. Through a series of technical validations, we illustrate that the data are of high quality and that the sequenced fragments represent methylated genomic regions. Furthermore, genes previously described to be methylated in NB are confirmed. As such, these MBD sequencing data are a valuable resource to further study the association of NB risk factors with the NB methylome, and offer the opportunity to integrate methylome data with other -omic data sets on the same tumor samples such as gene copy number and gene expression, also publically available.

Authors: Decock A, Ongenaert M, Van Criekinge W, Speleman F, Vandesompele J

Meer informatie: http://www.ncbi.nlm.nih.gov/pubmed/26836295

Terug naar News

Post date: 10 februari 2016
Copyright 2022 Centrum Medische Genetica, Gent.